Acute vasoreactivity testing for severe pulmonary hypertension associated with lung disease

Back

ESC Professional Premium Access

Acute vasoreactivity testing for severe pulmonary hypertension associated with lung disease

Session: Impact of pulmonary hypertension on quality of life and survival

Topic: Pulmonary Hypertension

Speaker: Doctor R. Takano (Suita, JP)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Ryo Takano

National Cerebral & Cardiovascular Center, Suita (Japan)

0 follower

7 more presentations in this session

Comparison of pulmonary arterial risk assessment tools to predict mortality or morbidity in treatment naive and previously diagnosed patients.

Speaker: Doctor C. Fauvel (Rouen, FR)

Prognostic value of follow-up hemodynamics after initial treatment in pulmonary arterial hypertension

Speaker: Doctor D. Guarino (Bologna, IT)

Multiparametric risk predictions for morbidity and mortality in patients with pulmonary arterial hypertension: insights from a nation-wide registry

Speaker: Professor C. Kaymaz (Istanbul, TR)

Health care utilisation in patients with mild pulmonary hypertension - EVIDENCE-PAH UK study

Speaker: Doctor N. Karia (London, GB)

Does the presence of severe pulmonary hypertension affect survival at 5 years follow-up in patients who underwent TAVI for severe aortic stenosis?

Speaker: Doctor H. Mohiaddin (Leicester, GB)

Access the full session

Impact of pulmonary hypertension on quality of life and survival

Speakers: Doctor R. Takano, Doctor C. Fauvel, Doctor D. Guarino, Professor C. Kaymaz, Doctor N. Karia...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources